IceCure Medical

Youtube Subscribe

Ticker: ICCM

Sector: Medical Devices

IceCure Medical

IceCure Medical shares drop 37% after fda denies de novo classification request - marketwatch. icecure medical shares drop. 37% at 57 cents. IceCure Medical Ltd (NASDAQ:ICCM) was down, falling 36% to $0.58 after the company announced the FDA has at this time denied its De Novo Classification request for breast cancer. IceCures Medical shares drop 37% after fda denies de novo classification request. IceCure Medical Ltd. develops and markets ProSense, an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors (benign and cancerous) by freezing. The primary focus areas are breast, kidney, bone and lung cancer.